Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting.
about
Acetylsalicylic Acid resistance in patients with type 2 diabetes mellitus, prediabetes & non-diabetic coronary artery disease.Potential Usefulness of Clopidogrel Pharmacogenetics in Cerebral Endovascular Procedures and Carotid Artery Stenting.Anti-platelet drug resistance in the prediction of thromboembolic complications after neurointerventionSignificance of clopidogrel resistance related to the stent-assisted angioplasty in patients with atherosclerotic cerebrovascular disease.Antiplatelet resistance and thromboembolic complications in neurointerventional procedures.Neurointerventional Stenting and Antiplatelet Function Testing: To Do or Not to Do?Prevention of stent thrombosis with reduced dose of prasugrel in two patients undergoing treatment of cerebral aneurysms with pipeline embolisation devices.The influence of anti-platelet resistance on the development of cerebral ischemic lesion after carotid artery stentingDevelopments on the horizon in the treatment of neurovascular problems.Establishing a predictive model for aspirin resistance in elderly Chinese patients with chronic cardiovascular diseaseDoes i-T744C P2Y12 Polymorphism Modulate Clopidogrel Response among Moroccan Acute Coronary Syndromes Patients?Safety and Efficacy of Intensified Antiplatelet Therapy in Patients Undergoing Neuroendovascular Procedures.In-stent stenosis in the patient with internal carotid aneurysm after treated by the Willis covered stent: Two case reports and literature review.Stent-assisted coil embolization of intracranial aneurysms using the Solitaireā¢ AB Neurovascular Remodeling Device: initial and midterm follow-up results.Clopidogrel Resistance by P2Y12 Platelet Function Testing in Patients Undergoing Neuroendovascular Procedures: Incidence of Ischemic and Hemorrhagic Complications.High on-treatment platelet reactivity in peripheral endovascular procedures.Stent-assisted coiling versus coiling in treatment of intracranial aneurysm: a systematic review and meta-analysis.Dual antiplatelet therapy plus postoperative heparin and dextran is safe and effective for reducing risk of embolic stroke during aneurysm coiling.The role of antiplatelet therapy in aneurysm coiling.Platelet function inhibitors and platelet function testing in neurointerventional procedures.Efficacy of clopidogrel treatment and platelet responsiveness in peripheral arterial procedures.Global Trends in Aspirin Resistance-Related Research from 1990 to 2015: A Bibliometric Analysis.Association between CYP2C19 Polymorphisms and Outcomes in Cerebral Endovascular Therapy.Diabetes mellitus and carotid artery plaques exhibiting high-intensity signals on MR angiography are related to increased platelet reactivity after carotid artery stenting.Double Stent Assist Coiling of Ruptured Large Saccular Aneurysm in Proximal Basilar Artery Fenestration.Is clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms?Preinterventional clopidogrel response variability for coil embolization of intracranial aneurysms: clinical implications.Platelet aggregation in intracranial stents may mimic in-stent restenosis.Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.Clopidogrel responsiveness in patients undergoing peripheral angioplasty.Incidence of microemboli and correlation with platelet inhibition in aneurysmal flow diversion.Hypertension as a risk factor for aspirin and clopidogrel resistance in patients with stable coronary artery disease.Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting.Factors associated with aspirin resistance in patients premedicated with aspirin and clopidogrel for endovascular neurosurgery.Measurement of antiplatelet inhibition during neurointerventional procedures: the effect of antithrombotic duration and loading dose.A new self-expandable nitinol stent for the treatment of wide-neck aneurysms: initial clinical experience.Complication rates using balloon-expandable and self-expanding stents for the treatment of intracranial atherosclerotic stenoses : analysis of the INTRASTENT multicentric registry.Clopidogrel Resistance in Neurovascular Stenting: Correlations between Light Transmission Aggregometry, VerifyNow, and the Multiplate.Carotid artery stenting outcomes: do they correlate with antiplatelet response assays?P2Y12 Reaction Units: Effect on Hemorrhagic and Thromboembolic Complications in Patients With Cerebral Aneurysms Treated With the Pipeline Embolization Device.
P2860
Q33722562-CE406E63-5004-42A3-8E5D-F76036948C4DQ33818356-96F5EF6F-5AEA-4681-A14F-1A7216E70826Q34316378-776A7950-342D-4726-A5C2-F4BC7043FB6DQ35176063-2D1F54DD-6B8D-4A4B-9DF6-49136B013111Q35750126-62A93898-D660-4706-AE5D-25248BE6A143Q35905832-9F73DE5C-EF88-4465-99FF-42B71A179843Q35982951-99DDE0B8-CAE3-40D0-B5E7-A8305D3093F1Q36620421-9322F789-1A51-4FEF-BE66-1CCAD66CCC37Q36812878-0F71B90E-C270-4A89-8158-54124CC4049AQ37174269-95E6B3D9-5A22-447C-8233-05CB2D71C5C7Q37651530-F37F925B-CC07-4E1C-B1A7-2EDB63B637B6Q37652931-7C8321B8-B5A7-4055-84C1-A1F651B7083BQ37656301-368AC4D3-58AD-485B-A9E4-84328761FFFAQ38079538-B87DC03C-F45B-4FFE-86B7-BF0032EE55E1Q38119235-F8D89EA6-1394-465D-876B-87DCF1F5929FQ38125134-CB267EDE-FE9A-4222-B3D0-CD5AF9F7AEB0Q38181098-96D861FF-3820-46FA-9234-737629FB65C1Q38193338-22AE0807-0A36-485A-8DCC-6FD85F8BDCE4Q38195112-DE25F5FE-856A-4E76-95A9-EB910832ABA6Q38233284-06391DB4-FB17-4B26-A344-60B76F50E8D8Q38243854-76536786-A041-425D-9554-CF023FD2D420Q38664158-BCBCA9CF-BF70-4837-BD89-B97761BF218DQ40575125-B7EF9B87-25D3-4DF7-8109-01601FAA1B4DQ40670841-D18B3E51-F54B-4869-826C-19C60C982CD9Q41927165-4E57BC67-B0EB-459A-B1A9-CFCE4AE615FAQ42876416-788B7CB9-4616-4954-8C0E-F06069932C1EQ43132755-C6376A54-FBD1-46CA-A84F-EF561091B2D0Q43260547-D1587B4F-D226-4358-AFF6-ACBE10D53C7EQ43652213-B5E281AC-0C8A-4BC8-BE89-5FABF9C714E0Q43767100-5BC66E92-2EB4-4809-B9E1-24A99E9E3718Q43832091-B5A0C8CC-75E4-43BB-9A59-604AC2C06127Q44277034-553FBB1E-FCAC-4027-AD31-A1115CA63D30Q44299095-66DF5C2F-9CB7-4C79-889E-F0CFA7F58CB6Q46087815-4914BAA2-D1AC-4210-A727-2B6EA9B496B3Q46115233-EB0638DF-4FCE-416C-BFCD-6A8229BBBF2DQ46626905-6076C0FD-642C-44D1-B839-9704E32B70F0Q50119538-7C502B60-A175-4ED3-A75D-D6D5C0C2DEF0Q50867606-35CF2563-7D08-4016-A017-64F1F23BD3B6Q50883518-DA3439DC-5A4D-48DE-A467-31032CE726A3Q51644306-59C777C5-A9CD-4511-9A49-B6844C1303B4
P2860
Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting.
description
2007 nĆ® lÅ«n-bĆ»n
@nan
2007幓ć®č«ę
@ja
2007幓å¦ęÆęē«
@wuu
2007幓å¦ęÆęē«
@zh
2007幓å¦ęÆęē«
@zh-cn
2007幓å¦ęÆęē«
@zh-hans
2007幓å¦ęÆęē«
@zh-my
2007幓å¦ęÆęē«
@zh-sg
2007幓åøč”ęē«
@yue
2007幓åøč”ęē«
@zh-hant
name
Prevalence and risk factors fo ...... e in cerebrovascular stenting.
@en
Prevalence and risk factors fo ...... e in cerebrovascular stenting.
@nl
type
label
Prevalence and risk factors fo ...... e in cerebrovascular stenting.
@en
Prevalence and risk factors fo ...... e in cerebrovascular stenting.
@nl
prefLabel
Prevalence and risk factors fo ...... e in cerebrovascular stenting.
@en
Prevalence and risk factors fo ...... e in cerebrovascular stenting.
@nl
P2093
P2860
P356
P1476
Prevalence and risk factors fo ...... e in cerebrovascular stenting.
@en
P2093
P2860
P304
P356
10.3174/AJNR.A0818
P577
2007-11-07T00:00:00Z